Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance
Authors:
- 26 October 2016
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 36 (6) , 3427-3435
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 23 references indexed in Scilit:
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Hepatocellular carcinoma: A comprehensive reviewWorld Journal of Hepatology, 2015
- Hepatocellular carcinoma: From diagnosis to treatmentWorld Journal of Hepatology, 2015
- HACE1, a Potential Tumor Suppressor Gene on 6q21, Is Not Involved in Extranodal Natural Killer/T-Cell Lymphoma PathophysiologyThe American Journal of Pathology, 2014
- Treatment of Hepatocellular CarcinomaDigestive Diseases, 2014
- Ubiquitylation of Autophagy Receptor Optineurin by HACE1 Activates Selective Autophagy for Tumor SuppressionCancer Cell, 2014
- Gene methylation in gastric cancerClinica Chimica Acta, 2013
- Ubiquitylation of active Rac1 by the E3 Ubiquitin-Ligase HACE1Small GTPases, 2012
- The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancersNature Medicine, 2007
- Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidneyHuman Molecular Genetics, 2004